Fig. 1From: Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approachSchematic specifications of the structure of a 543-amino-acid-long multi-epitope vaccine. Adjuvant with EAAAK linker is added to the beginning and end of the structure, and CTL, HTL and B cell epitopes are connected with AAY, GPGPG and KK linkers, respectivelyBack to article page